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Abstract
Background: Encapsulating peritoneal sclerosis (EPS) is classically described as progressive sclerosis and cocooning
of the entire peritoneum; however, there has been limited number of reported cases of localized fibrosis as a
variant form.
Case presentation: We describe two cases of acute bowel obstruction with isolated transition points in the setting
of long-term peritoneal dialysis.
Conclusion: We postulate that some of the cases of small bowel obstruction with an obvious transition point in
long-term peritoneal dialysis patients may represent a unique and localized form of EPS. We aim to emphasize the
presence of macroscopic variations in presentation of EPS.
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Background
Encapsulating peritoneal sclerosis (EPS) is a rare but
devastating complication of long-term peritoneal dialysis
(PD). It is characterized by progressive thickening and fi-
brosis of the peritoneal membrane, which eventually
leads to encapsulation of the abdominal content by the
abnormal fibrous tissue [1].
The incidence of EPS increases with time on PD, and
presents most frequently after cessation of the therapy.
Kawanishi et al. reported an incidence of 17.2 % after
15 years of PD therapy [2–5]. Similarly, the mortality
rate from EPS increases with increased time on PD. For
example, in the Pan-Thames EPS study, 42 and 100 % of
patients succumbed at 3 and 15 years respectively [6].
Duration of exposure to PD therapy seems to be the
principal risk factor for developing EPS, along with other
currently identified factors including young age, genetic
predisposition, and receipt of a kidney transplant.
There is an early inflammatory prodrome in many
cases that can be missed. Manifestations include vague
abdominal discomfort or anorexia, new-onset infusion
pain, hemoperitoneum, and development of rapid trans-
port status. Other clinical symptoms of EPS are directly
related to disturbances in gastrointestinal transit, due to
abnormal fibrous tissue formation around the bowel
loops. The most common findings are abdominal pain,
nausea, vomiting, anorexia, abdominal fullness, and
eventually partial or complete small-bowel obstruction.
Since the initial signs and symptoms of EPS are non-
specific and subtle, a high index of suspicion is needed
to establish an early diagnosis [7–9].
The classical macroscopic appearance of advanced
EPS is total encapsulation of the bowel by a fibrotic
membrane [10]. Laparotomy has usually revealed a
thickened, brownish peritoneum with adhesions, and in-
testines that are partially or totally encapsulated in thick
fibrous tissue. In advanced cases, a sclerotic layer has
completely covered the intestines, giving the appearance
of a cocoon [11, 12].
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Localized involvement of parts of the bowel with fibro-
sis has been reported in the past, and it has been sug-
gested that it could be more common than previously
recognized [13, 14].
We report two cases of bowel obstruction with obvi-
ous transition point, appearing to be localized, which
happened in patients after being on PD for many years.
We postulate that localized fibrosis represents an atyp-
ical form of EPS.
Case presentation
Case 1
A 31-year-old woman was admitted with symptoms and
signs of bowel obstruction. She had been diagnosed with
systemic lupus erythematosus (SLE) about 14 years pre-
viously, and experienced multiple complications of SLE,
including lupus nephritis, cerebritis and pleuritis. She
had been on PD for 8 years. Other comorbidities in-
cluded hypertension, hyperlipidemia and chronic
anemia. She was on the waiting list for renal transplant
at the time of presentation to the hospital. She had no
history of peritonitis, and her PD treatment was un-
eventful. On initial 4-h peritoneal equilibrium test
(PET), Dialysate/Plasma Creatinine (D/P Cr) was 0.71
(high-average transporter). Her lupus had otherwise
been under control with no manifestations of active dis-
ease. There was no history of previous bowel surgeries
or bowel obstruction.
She presented with a history of nausea, vomiting and
abdominal pain, with report of not having had flatus or
bowel movements for a few days.
Plain radiography showed dilated small bowel loops,
with several air-fluid levels on the erect view (Fig. 1).
To further investigate, computed tomography (CT) of
the abdomen was obtained which showed dilated small
bowel loops measuring up to 3.6 cm, with a transition
point in the pelvis, where distal to this point the ileal
loops were collapsed; the colon was relatively collapsed
as well (Fig. 2).
Inflammatory markers included declining serum albu-
min level for the past few months with a nadir of 23 g/L,
and erythrocyte sedimentation rate (ESR) of 38 mm/first
hour.
The surgery service recommended non-operative man-
agement, with resting the bowels, and insertion of a
nasogastric tube. The PD therapy was held in the setting
of bowel obstruction; a hemodialysis line was inserted to
initiate hemodialysis. The patient eventually recovered
with this approach, and was tolerating oral intake upon
discharge from the hospital. She elected to stay on
hemodialysis after this presentation.
Case 2
A 57-year-old female was admitted to the hospital with
signs and symptoms of bowel obstruction.
Her past medical history included a diagnosis of anti-
phospholipid antibody syndrome (APLAS) on anticoagu-
lation, end-stage kidney disease, multiple previous
arterial and venous thrombotic events, congestive heart
failure, previous mitral valve replacement, atrial fibrilla-
tion, hepatitis C, and hypothyroidism. She had been
started on PD in the form of continuous ambulatory PD
(CAPD) 5 years prior to the current presentation. As
with the first patient, there had been no peritonitis dur-
ing her 5-year course of PD. There was no history of
bowel surgery or bowel obstruction. On initial 4-h PET,
D/P Cr was 0.78 (high-average transporter).
Fig. 1 Plain abdominal radiography, upright view, showing several
air-fluid levels
Fig. 2 CT abdomen showing dilated bowel loops with transition
point (arrow) in pelvis
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Upon presentation to the emergency department, she
reported a 10-day history of nausea, vomiting, abdom-
inal distension and pain, and absence of bowel
movement.
To further investigate, a CT abdomen was per-
formed which revealed fluid and gas distended loops
of proximal small bowel, measuring up to 4.3 cm in
diameter. This extended to the pelvis, where there
was a focal cluster of distal loops displaced abnor-
mally into the left lower pelvis with multiple transi-
tion points. The appearance was in keeping with a
closed-loop distal small bowel obstruction (Fig. 3).
An exploratory laparotomy was performed during
which a highly abnormal mass of small bowel loops
was noted in the left lower quadrant, where the
bowel loops could not be separated. Pathology report
of the mass indicated a high degree of localized
fibrous serosal adhesion. The abnormal mass of bowel
loops was resected, with residual small bowel length
of 170 cm. Similar to the previous case, serum albu-
min declined rapidly from a normal baseline over the
preceding few months, with a nadir of 20 g/L. Other
inflammatory markers were not obtained at this time.
The PD catheter was removed during this operation,
and the patient was permanently transitioned to
hemodialysis.
Discussion
We present two cases of bowel obstruction with transi-
tion point in the context of long term peritoneal dialysis.
Patients with longstanding PD and concurrent auto-
immune disease have previously identified as being par-
ticularly at risk for EPS [13]. EPS has classically been
described as marked thickening and sclerosis of the en-
tire peritoneal surface, a retraction of the root of the
mesentery, and striking finding of encasement of the en-
tire small bowel. There has been, however, limited num-
ber of case reports, describing “localized” EPS. Kirkman
et al. reported a case of localized encapsulation of small
bowel loops at the level of terminal ileum in a post-
transplant patient previously on longstanding PD
therapy [14].
Similarly Habib et al. reported 3 cases of “localized”
EPS, where intra-operatively, an obvious sclerotic and
thickened peritoneal membrane was observed, predom-
inantly covering and constricting the terminal ileum
[15].
By reporting these cases, although surgical exploration
was not performed in our first case, we aim to
emphasize the presence of macroscopic variations in
presentation of EPS. We speculate that some of the
cases of localized small bowel obstruction, with obvious
transition points, in the context of prolonged PD
Fig. 3 CT abdomen showing closed-loop small bowel obstruction, with multiple transition points (arrows: a, b, c) with abnormally displaced loops
to the left lower pelvis (b, c)
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therapy, may in fact represent non-classic forms of EPS.
The approach to management of these patients should
therefore be similar to those proposed for the more
generalized form of encapsulation. A conservative ap-
proach with resting the bowels should be tried, and in
cases where the index of suspicion for EPS is significant,
we suggest termination of PD and switching to a differ-
ent dialysis modality. In case of persistent bowel
obstruction despite conservative management, a surgical
approach is suitable, as described in our second case, in
addition to termination of PD. Further case studies are
needed to investigate the use of pharmacologic agents
such as tamoxifen or corticosteroids.
Conclusion
It is suggested that clinicians have a high index of suspi-
cion for EPS in patients on long-term PD therapy who
present with acute bowel obstruction with an isolated
transition point.
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